Bio-Techne (TECH) FCF Payout Ratio Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) FCF Payout Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 9.12% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -6.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.13% |
| Mar 31, 2026 | -20.77% |
| Dec 31, 2025 | -8.89% |
| Sep 30, 2025 | 27.58% |
| Jun 30, 2025 | -1.91% |
| Mar 31, 2025 | 23.26% |
| Dec 31, 2024 | 5.86% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | 24.99% |
| Mar 31, 2024 | 0.21% |
| Dec 31, 2023 | 4.94% |
| Sep 30, 2023 | 7.25% |
| Jun 30, 2023 | -27.04% |
| Mar 31, 2023 | 2.01% |
| Dec 31, 2022 | -0.43% |
| Sep 30, 2022 | -12.71% |
| Jun 30, 2022 | -19.93% |
| Mar 31, 2022 | -14.60% |
| Dec 31, 2021 | -21.66% |
| Sep 30, 2021 | -4.84% |